◼ Archived
Business
🔮 Newsylist predicts: still trending tomorrow high confidence — graded ✗ wrong
Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
5sources
5articles
3velocity
+0%since first seen
62d agofirst detected
Text:
🤖 AI Dossier
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Who reported it (5)
-
-
-
-
-
Novo Nordisk’s ziltivekimab stumbles again on pair of Phase III terminations Clinical Trials Arena · 63d ago broke it first
📊 AUDIENCE & LONGEVITY PULSE
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Related trends
▲ Peaking
Business
Delta adding summer destinations from Detroit, extending other seasonal routes
▲ Peaking
Business
Tech sell-off raises risks for SoftBank’s massive AI bet
▲ Peaking
Business
Gold gains as lower oil prices ease inflation fears
🔥 Breakout ↑ Rising
Business
US employers keep passing rising healthcare costs to workers. There are better options
↑ Rising
Business
Your job-based insurance cut GLP-1 coverage. Here are some options
▲ Peaking
Business